JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Association of LACC1, CEBPB - PTPN1, RIPK2 and ADO-EGR2 with ocular Behcet's disease in a Chinese Han population.

BACKGROUND: An Immunochip study recently identified the association of a number of new genetic loci with Behcet's disease (BD).

OBJECTIVE: To confirm the association between new genetic loci reported in an Immunochip study and BD in a Han Chinese population.

METHODS: A two-stage association study was carried out in 1238 patients with BD and 1458 healthy controls. Twenty-two candidate single nucleotide polymorphisms (SNPs) were selected for genotyping by iPLEXGold genotyping or TaqMan SNP assays and a meta-analysis was performed for significantly associated markers.

RESULTS: The results showed that four SNPs ( LACC1 /rs9316059, CEBPB-PTPN1 /rs913678, ADO-EGR2 /rs224127 and RIPK2 /rs10094579) were associated with BD in an allelic association test (rs9316059 T allele: pc =4.95×10-8 , OR=0.687; rs913678 C allele: pc =3.01×10-4 , OR=1.297; rs224127 A allele: pc =3.77×10-4 , OR=1.274; rs10094579 A allele: pc =6.93×10-4 , OR=1.302). For four SNPs tested by meta-analysis, the association with BD was strengthened and all exceeded genome-wide significance (rs9316059: p=2.96×10-16 ; rs913678: p=2.09×10-16 ; rs224127: p=5.28×10-13 ; rs10094579: p=9.21×10-11 ).

CONCLUSIONS: Our findings confirmed the association of four loci ( LACC1 , CEBPB-PTPN1 , ADO-EGR2 and RIPK2 ) in Chinese Han patients with BD.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app